Hot Stocks Canopy Growth announces launch of Martha Stewart CBD » Canopy Growth $16.37 / +0.77 (+4.94%) CGC Canopy Growth announced… Canopy Growth announced the launch of Martha Stewart CBD, a new line of hemp-derived wellness supplements, with flavor profiles inspired by some of Martha's most popular recipes. The initial product offering will include a range of human wellness supplements, with a gift box and pet line launching later this year. The new portfolio of natural wellness gummies, softgels and oil drops are formulated by Martha Stewart, in collaboration with the cannabinoid scientists at Canopy Growth, to deliver a daily dose of pure, premium CBD isolate. Inspired by ingredients in Martha's own kitchen, the products are naturally flavored and are made in the USA with hemp-derived CBD isolate. Show Hide Related Items >> << Company News

Street Research

Earnings

Periodicals

On The Fly

Options CGC Canopy Growth $16.37 / +0.77 (+4.94%) 09/09/20 Acreage says ISS, Glass Lewis support plan of arrangement for Canopy Growth 08/28/20 Canopy Growth to open 10 brick-and-mortar retail cannabis locations in Alberta 08/18/20 Acreage files proxy statement related to amended Canopy Growth arrangement 08/10/20 Canopy Growth expects gross margins to be pressured, sees Q2 GM below 20% CGC Canopy Growth $16.37 / +0.77 (+4.94%) 08/31/20 Roth Capital Roth Capital believes MORE Act will not pass in 2020 08/11/20 Canaccord Canopy Growth price target raised to C$22 from C$21 at Canaccord 07/02/20 HSBC Constellation Brands price target raised to $170 from $147 at HSBC 06/24/20 Cantor Fitzgerald Aurora Cannabis price target raised to C$29 from C$27 at Cantor Fitzgerald CGC Canopy Growth $16.37 / +0.77 (+4.94%) 08/26/20 Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219 08/10/20 Canopy Growth reports Q2 EPS (C30c) vs. (C54c) last year 07/01/20 Constellation Brands reports Q1 comparable EPS ex. Canopy Growth losses $2.44 05/29/20 Canopy Growth reports Q4 EPS (C$3.72) vs. (C$1.10) a year ago CGC Canopy Growth $16.37 / +0.77 (+4.94%) 08/31/20 U.S. House to vote to remove marijuana from controlled substance list, Hill says 08/18/20 Cannabis startup gets investment from former Starbucks CEO, Crunchbase News says 05/13/20 Coronavirus relief bill includes marijuana banking, Marijuana Moment say 05/07/20 Researchers develop chemistry needed for marijuana breathalyzer, UCLA reports CGC Canopy Growth $16.37 / +0.77 (+4.94%) 09/03/20 Rising High: Cannabis firms report second quarter earnings 08/27/20 Rising High: An exclusive talk with cannabis products company CordovaCann 08/20/20 Rising High: An exclusive talk with hemp health and wellness company Omnicanna 08/13/20 Rising High: An exclusive talk with Cresco Labs co-founder Joe Caltabiano CGC Canopy Growth $16.37 / +0.77 (+4.94%) 09/09/20 Canopy Growth call volume above normal and directionally bullish 09/03/20 Canopy Growth call volume above normal and directionally bullish 08/07/20 Largest borrow rate increases among liquid names 07/30/20 Canopy Growth call volume above normal and directionally bullish

Options Canopy Growth call volume above normal and directionally bullish » Canopy Growth $16.26 / +0.66 (+4.23%) CGC Bullish option flow… Bullish option flow detected in Canopy Growth with 10,015 calls trading, 1.1x expected, and implied vol increasing almost 14 points to 80.25%. Sep-20 16.5 calls and 9/11 weekly 16.5 calls are the most active options, with total volume in those strikes near 4,400 contracts. The Put/Call Ratio is 0.26. Earnings are expected on November 9th. Show Hide Related Items >> << Company News

Street Research

Earnings

Periodicals

On The Fly

Options CGC Canopy Growth $16.26 / +0.66 (+4.23%) 09/09/20 Acreage says ISS, Glass Lewis support plan of arrangement for Canopy Growth 08/28/20 Canopy Growth to open 10 brick-and-mortar retail cannabis locations in Alberta 08/18/20 Acreage files proxy statement related to amended Canopy Growth arrangement 08/10/20 Canopy Growth expects gross margins to be pressured, sees Q2 GM below 20% CGC Canopy Growth $16.26 / +0.66 (+4.23%) 08/31/20 Roth Capital Roth Capital believes MORE Act will not pass in 2020 08/11/20 Canaccord Canopy Growth price target raised to C$22 from C$21 at Canaccord 07/02/20 HSBC Constellation Brands price target raised to $170 from $147 at HSBC 06/24/20 Cantor Fitzgerald Aurora Cannabis price target raised to C$29 from C$27 at Cantor Fitzgerald CGC Canopy Growth $16.26 / +0.66 (+4.23%) 08/26/20 Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219 08/10/20 Canopy Growth reports Q2 EPS (C30c) vs. (C54c) last year 07/01/20 Constellation Brands reports Q1 comparable EPS ex. Canopy Growth losses $2.44 05/29/20 Canopy Growth reports Q4 EPS (C$3.72) vs. (C$1.10) a year ago CGC Canopy Growth $16.26 / +0.66 (+4.23%) 08/31/20 U.S. House to vote to remove marijuana from controlled substance list, Hill says 08/18/20 Cannabis startup gets investment from former Starbucks CEO, Crunchbase News says 05/13/20 Coronavirus relief bill includes marijuana banking, Marijuana Moment say 05/07/20 Researchers develop chemistry needed for marijuana breathalyzer, UCLA reports CGC Canopy Growth $16.26 / +0.66 (+4.23%) 09/03/20 Rising High: Cannabis firms report second quarter earnings 08/27/20 Rising High: An exclusive talk with cannabis products company CordovaCann 08/20/20 Rising High: An exclusive talk with hemp health and wellness company Omnicanna 08/13/20 Rising High: An exclusive talk with Cresco Labs co-founder Joe Caltabiano CGC Canopy Growth $16.26 / +0.66 (+4.23%) 09/03/20 Canopy Growth call volume above normal and directionally bullish 08/07/20 Largest borrow rate increases among liquid names 07/30/20 Canopy Growth call volume above normal and directionally bullish 07/29/20 Unusually active option classes on open July 29th

Hot Stocks Acreage says ISS, Glass Lewis support plan of arrangement for Canopy Growth » Acreage Holdings $0.00 / + (+0.00%) ACRGF Canopy Growth $15.59 / -0.62 (-3.82%) CGC Acreage Holdings… Acreage Holdings announced that Institutional Shareholder Services and Glass, Lewis & Co. have each recommended that Acreage shareholders vote "FOR" the resolution to approve, among other things, the Amended Arrangement at Acreage's special meeting of shareholders on Wednesday, September 16, 2020. In reaching its recommendation, ISS stated the following: "The proposed amended arrangement with Canopy Growth appears to offer shareholders the best path forward. The amended arrangement with Canopy Growth will provide [a subsidiary of] the company with additional funding, an up-front cash payment to shareholders, and additional optionality that the newly-created share classes may be acquired at a significant premium to the unaffected share price." The recommendation from ISS follows the report from Glass Lewis, who also recommended that shareholders vote "FOR" the Amendment Resolution, noting that: "In our assessment, the reduced exchange ratio for the new Fixed Shares in an eventual acquisition by Canopy appears to have been at least made up by the introduction of new Floating Shares, based on the agreed minimum value of the Floating Shares when and if they are acquired by Canopy and the relative value of the companies' share prices at the time the Existing and Amended Arrangement Agreements were signed. We recognize that the Amended Arrangement preserves shareholder value, offers further potential upside, yields additional upfront cash for shareholders and provides financial and management resources which are needed by the Company during this challenging period." Show Hide Related Items >> << Company News

Street Research

Earnings

Periodicals

On The Fly

Options CGC

ACRGF CGC Canopy Growth $15.59 / -0.62 (-3.82%) 08/28/20 Canopy Growth to open 10 brick-and-mortar retail cannabis locations in Alberta 08/10/20 Canopy Growth expects gross margins to be pressured, sees Q2 GM below 20% 08/10/20 Canopy Growth rises 11.6% ACRGF Acreage Holdings $0.00 / + (+0.00%) 08/18/20 Acreage files proxy statement related to amended Canopy Growth arrangement 08/12/20 Acreage Holdings announces sale of Maryland dispensary 07/09/20 Acreage gets provisional OK to sell adult-use cannabis at 2 Massachusetts sites 06/30/20 Surna appoints Randy Shipley, Nick Etten to board of directors ACRGF

CGC ACRGF Acreage Holdings $0.00 / + (+0.00%) 02/14/20 Cantor Fitzgerald Cantor initiates 10 cannabis names, sees opportunity after sellofff 02/13/20 Cantor Fitzgerald Acreage Holdings initiated with a Neutral at Cantor Fitzgerald 10/31/19 Ladenburg Cannabis sector investor sentiment is now 'very low,' says Ladenburg 09/20/19 MKM Partners MKM starts Acreage at Buy on 'extreme disconnect' from Canopy offer CGC Canopy Growth $15.59 / -0.62 (-3.82%) 08/31/20 Roth Capital Roth Capital believes MORE Act will not pass in 2020 08/11/20 Canaccord Canopy Growth price target raised to C$22 from C$21 at Canaccord 07/02/20 HSBC Constellation Brands price target raised to $170 from $147 at HSBC 06/24/20 Cantor Fitzgerald Aurora Cannabis price target raised to C$29 from C$27 at Cantor Fitzgerald CGC

ACRGF CGC Canopy Growth $15.59 / -0.62 (-3.82%) 08/26/20 Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219 08/10/20 Canopy Growth reports Q2 EPS (C30c) vs. (C54c) last year 07/01/20 Constellation Brands reports Q1 comparable EPS ex. Canopy Growth losses $2.44 05/29/20 Canopy Growth reports Q4 EPS (C$3.72) vs. (C$1.10) a year ago ACRGF Acreage Holdings $0.00 / + (+0.00%) 04/03/20 Acreage Holdings suspends previous 2020 financial targets CGC CGC Canopy Growth $15.59 / -0.62 (-3.82%) 08/31/20 U.S. House to vote to remove marijuana from controlled substance list, Hill says 08/18/20 Cannabis startup gets investment from former Starbucks CEO, Crunchbase News says 05/13/20 Coronavirus relief bill includes marijuana banking, Marijuana Moment say 05/07/20 Researchers develop chemistry needed for marijuana breathalyzer, UCLA reports CGC CGC Canopy Growth $15.59 / -0.62 (-3.82%) 09/03/20 Rising High: Cannabis firms report second quarter earnings 08/27/20 Rising High: An exclusive talk with cannabis products company CordovaCann 08/20/20 Rising High: An exclusive talk with hemp health and wellness company Omnicanna 08/13/20 Rising High: An exclusive talk with Cresco Labs co-founder Joe Caltabiano CGC CGC Canopy Growth $15.59 / -0.62 (-3.82%) 09/03/20 Canopy Growth call volume above normal and directionally bullish 08/07/20 Largest borrow rate increases among liquid names 07/30/20 Canopy Growth call volume above normal and directionally bullish 07/29/20 Unusually active option classes on open July 29th

Options Canopy Growth call volume above normal and directionally bullish » Canopy Growth $16.38 / +0.02 (+0.12%) CGC Bullish option flow… Bullish option flow detected in Canopy Growth with 37,252 calls trading, 1.7x expected, and implied vol increasing almost 30 points to 108.81%. Sep-20 17 calls and Oct-20 20 calls are the most active options, with total volume in those strikes near 17,300 contracts. The Put/Call Ratio is 0.09. Earnings are expected on November 9th. Show Hide Related Items >> << Company News

Street Research

Earnings

Periodicals

On The Fly

Options CGC Canopy Growth $16.38 / +0.02 (+0.12%) 08/28/20 Canopy Growth to open 10 brick-and-mortar retail cannabis locations in Alberta 08/18/20 Acreage files proxy statement related to amended Canopy Growth arrangement 08/10/20 Canopy Growth expects gross margins to be pressured, sees Q2 GM below 20% 08/10/20 Canopy Growth rises 11.6% CGC Canopy Growth $16.38 / +0.02 (+0.12%) 08/31/20 Roth Capital Roth Capital believes MORE Act will not pass in 2020 08/11/20 Canaccord Canopy Growth price target raised to C$22 from C$21 at Canaccord 07/02/20 HSBC Constellation Brands price target raised to $170 from $147 at HSBC 06/24/20 Cantor Fitzgerald Aurora Cannabis price target raised to C$29 from C$27 at Cantor Fitzgerald CGC Canopy Growth $16.38 / +0.02 (+0.12%) 08/26/20 Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219 08/10/20 Canopy Growth reports Q2 EPS (C30c) vs. (C54c) last year 07/01/20 Constellation Brands reports Q1 comparable EPS ex. Canopy Growth losses $2.44 05/29/20 Canopy Growth reports Q4 EPS (C$3.72) vs. (C$1.10) a year ago CGC Canopy Growth $16.38 / +0.02 (+0.12%) 08/31/20 U.S. House to vote to remove marijuana from controlled substance list, Hill says 08/18/20 Cannabis startup gets investment from former Starbucks CEO, Crunchbase News says 05/13/20 Coronavirus relief bill includes marijuana banking, Marijuana Moment say 05/07/20 Researchers develop chemistry needed for marijuana breathalyzer, UCLA reports CGC Canopy Growth $16.38 / +0.02 (+0.12%) 09/03/20 Rising High: Cannabis firms report second quarter earnings 08/27/20 Rising High: An exclusive talk with cannabis products company CordovaCann 08/20/20 Rising High: An exclusive talk with hemp health and wellness company Omnicanna 08/13/20 Rising High: An exclusive talk with Cresco Labs co-founder Joe Caltabiano CGC Canopy Growth $16.38 / +0.02 (+0.12%) 08/07/20 Largest borrow rate increases among liquid names 07/30/20 Canopy Growth call volume above normal and directionally bullish 07/29/20 Unusually active option classes on open July 29th 07/28/20 Canopy Growth call volume above normal and directionally bullish